Find Academic Supervisors

Kristina A. MatkowskyjView profile

Medical Educator

• Gastrointestinal Pathology
• Pancreaticobiliary Pathology
• Colorectal Cancer
• +5 more

Kristina A. Matkowskyj is a Medical Educator at the Mayo Clinic in Rochester, Minnesota. Her subspecialty focuses on Gastrointestinal and Pancreaticobiliary Pathology , with active contributions to Translational Research and the education of medical students and fellows. 2012 : Fellowship in Gastrointestinal and Liver Pathology, McGaw Medical Center, Northwestern University 2010 : Residency in Anatomic Pathology, McGaw Medical Center, Northwestern University 2007 : MD in Medicine, University of Illinois 2001 : PhD in Pathology, University of Illinois at Chicago 1997 : BS in Chemistry, University of Illinois Urbana-Champaign Her research interests center on Gastrointestinal Cancers , including Colorectal Cancer , Esophageal Cancer , Gastric Cancer , and Pancreatic Cancer , with a focus on Inflammatory Bowel Disease and Biomarker Testing for targeted therapies. Recent publications highlight her work on Claudin-18.2 Immunohistochemistry , Cancer-Associated Fibroblast Proteins , and Organoid Models for predicting treatment sensitivity. Dr. Matkowskyj serves on the CAP Cancer Committee , CAP HER2 Guideline Advisory Panel , and is an editorial board member for Human Pathology . Her collaborative publications span topics in Cancer Classification , Dietary Interventions , and Clinical Guidelines for oncology.

Aivi T. NguyenView profile

Assistant Clinical Professor

• Neurodegeneration
• Alzheimer's Disease
• Microglia
• +3 more

Aivi T. Nguyen, M.D., serves as a Clinical Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. As a board-certified neuropathologist and translational researcher, she spearheads investigations into neuroinflammation mechanisms in neurodegenerative diseases through the Alzheimer's Disease Research Center (ADRC) and Mayo Clinic Study of Aging (MCSA), integrating neuropathology with neuroimaging and biomarker analysis. Her educational trajectory includes: Post Doctoral Fellowship, Translational Neuropathology Research Laboratory (University of Pennsylvania, 2020) Neuropathology Fellowship (Hospital of the University of Pennsylvania, 2018) Anatomic Pathology Residency (Hospital of the University of Pennsylvania, 2016) M.D. (Jefferson Medical College, 2014) Research Fellowship (NIH Medical Research Scholars Program, 2013) B.S. in Cell and Molecular Biology, Genetics (University of Delaware, 2009) Dr. Nguyen's research centers on microglial heterogeneity in Alzheimer's disease, employing single-nuclei RNA sequencing and immunohistochemical validation to characterize distinct microglial subpopulations. She investigates how genetic risk variants (APOE E4, TREM2 R47H) modulate microglial responses to proteinopathies and explores microglia's role in cognitive resilience despite pathological burden. Her work bridges molecular mechanisms with clinical manifestations through multidisciplinary approaches. Analysis of her 2020-2025 publications reveals consistent focus on microglial biology across neurodegenerative conditions, with increasing emphasis on genetic determinants and translational applications. Recent work expands into TDP-43 proteinopathies and cerebral amyloid angiopathy while maintaining core investigation of microglial dynamics in Alzheimer's disease. Her accolades include: Two Diagnostic Slide Session Awards for Best Neurodegenerative Case (American Association of Neuropathology, 2021 & 2018) Neurodegenerative Disease Scholars Program Award and Robert Terry Award Honorable Mention (2020) Penn Cares Grant for 'Woodland Writers' Project (2015) Harold L. Stewart Prize in Pathology (2014) Dr. Nguyen actively shapes neuropathology standards through committee roles including the American Board of Pathology Test Development Advisory Committee and American Association of Neuropathologists Education Committee. Her research is supported by institutional resources within Mayo Clinic's ADRC infrastructure and collaborative multi-institutional grants. She operates within Mayo Clinic's integrated research ecosystem, contributing neuropathological expertise to the ADRC and MCSA teams while participating in national consortia studying neurodegenerative mechanisms. Her laboratory work focuses on human tissue analysis with emphasis on microglial transcriptomics and spatial pathology mapping.

Jonathan HallView profile

Assistant Professor

• Molecular Genetics
• Environmental Health Science
• Signal Transduction
• +5 more

Jonathan Hall is an Assistant Professor in the Department of Biological Sciences at North Carolina State University. He joined NC State in 2021 as part of the Chancellor’s Faculty Excellence Program in Environmental Health Science and is affiliated with the Center for Human Health and the Environment and the Genetics and Genomics Initiative. B.S. in Biochemistry, Michigan State University Ph.D. in Biochemistry and Biophysics, University of North Carolina at Chapel Hill Hall’s research investigates gene and signaling pathways that determine skin cancer susceptibility, focusing on cellular responses to DNA damage from UVB radiation, tumor stress, and infection. His work explores how epidermal cells balance survival and programmed cell death through interactions between C/EBPβ, p53, and type I interferon pathways. Recent publications highlight his work on transcriptional regulation (C/EBPβ, C/EBPα), DNA damage checkpoints, and environmental stress responses in skin and lung systems. Articles span topics from telomere architecture to exposome-wide association studies. NIEHS Ruth L. Kirschstein Fellowship recipient Hall’s lab employs molecular/cellular systems and genetically engineered mouse models to study mechanisms of skin cancer development. His research bridges environmental health science with fundamental molecular genetics and tumor biology.

Janet KumitaView profile

Researcher

• Protein Aggregation
• Neurodegenerative Diseases
• Biomolecular Condensates
• +3 more

Dr. Janet Kumita is a Researcher at the Department of Pharmacology , University of Cambridge , focusing on protein aggregation, amyloid formation, and neurodegenerative diseases such as Alzheimer's and Parkinson's. Her work explores the structural, biophysical, and cellular mechanisms of amyloidogenic proteins like alpha-synuclein and lysozyme, using advanced techniques such as microscopy , molecular simulations , and nanoscale optical tweezers . Major Research Themes : Biophysical properties of biomolecular condensates Role of post-translational modifications in protein misfolding Therapeutic strategies to modulate amyloid aggregation Key Article Trends : 2025: Microscopy techniques for condensate material properties 2024: Structural analysis of PR65 and synthetic condensates for protein degradation 2023: Tandem-repeat proteins, designer therapeutics, and N-terminal acetylation effects

Meritxell NusView profile

Research Fellow

• Atherosclerosis
• Immunology
• Cardiovascular Disease
• +4 more

Dr Meritxell Nus is a British Heart Foundation Intermediate Research Fellow and Associate Principal Investigator at the Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge. Her work bridges immunology, cardiovascular disease, and microbiome research with a focus on atherosclerosis mechanisms. Her educational background includes a PhD from Universidad Complutense de Madrid on functional food and oxidative stress in atherosclerosis, followed by postdoctoral training at Centro Nacional de Investigaciones Cardiovasculares (CNIC) where she developed the first mouse model of aortic calcific stenosis. She later joined Prof. Ziad Mallat's lab at Cambridge to investigate diet-immune interactions in cardiovascular disease. Dr Nus pioneered the discovery that Marginal Zone B cells protect against atherosclerosis through regulation of T follicular helper cells. Her current research examines how diet and gut microbiota modulate this B-T cell axis, with emphasis on metabolic pathways driving T follicular helper cell function. This work integrates advanced models of immune cell interactions, microbiome manipulation, and high-fat diet challenges. Analysis of her recent publications reveals consistent focus on lymphocyte interactions in atherosclerosis, with increasing incorporation of advanced imaging techniques (PET/MRI), neural network diagnostics, and microbiome-targeted interventions. Key themes include B-T cell crosstalk, cytokine signaling (IL-2, IL-21), and translational applications of immunomodulation. BHF Intermediate Research Fellowship BHF Project Grant (FS/20/23/34784): Metabolic pathways to Tfh differentiation BHF Project Grant (PG/22/10898): Targeting gut microbiota-adaptive immune axis LeDucq Foundation Mini Grant (20CVD03) Spanish Royal Academy of Doctors Prize National Academy of Pharmacy Prize Dr Nus leads multiple active grants totaling significant research funding. Her collaborative network includes Prof. Ziad Mallat (Cambridge), Prof. Christoph Reinhardt (Mainz), Dr Jason Tarkin (Cambridge), Dr Michelle Linterman (Babraham), and Dr Helle Jorgensen (Cambridge). Current projects investigate metabolic drivers of T follicular helper cells and gut microbiota modulation as therapeutic strategies for atherosclerosis. Her research group operates within the Cardiovascular Health division of the Dahdaleh Institute, utilizing advanced models of atherosclerosis, immune cell profiling, and microbiome analysis. Future work focuses on translating mechanistic insights into clinical applications for cardiovascular disease prevention.

John EssigmannView profile

Professor

• DNA Damage
• Mutagenesis
• Carcinogenesis
• +4 more

John Essigmann is the William R. (1956) and Betsy P. Leitch Professor in Residence of Chemistry at the Massachusetts Institute of Technology, with joint appointments in the Department of Chemistry and Department of Biological Engineering. He previously served as Director of the Center for Environmental Health Sciences (2012-2019) and Associate Head of the Department of Chemistry (until 2012). Currently, he directs the MIT T32 Training Grant in Toxicology and maintains an active research program focused on DNA damage mechanisms. His educational background includes undergraduate studies at Northeastern University and a Ph.D. from MIT under Professor Gerald Wogan, a pioneer in toxicology. His doctoral work investigated metabolic activation and DNA binding of aflatoxin B1 and related fungal toxins. Essigmann's research centers on understanding how DNA lesions caused by environmental toxins and chemotherapeutic drugs lead to mutations, cancer, and cell death. His laboratory pioneered methods to synthesize oligonucleotides containing specific DNA adducts and introduce them into viral genomes to study mutational outcomes. This work has provided fundamental insights into carcinogenesis mechanisms and informed the development of anticancer strategies like 'lethal mutagenesis.' His research spans molecular toxicology, DNA repair mechanisms, mutagenesis, and the molecular etiology of human cancer. Analysis of his recent publications reveals consistent focus on DNA damage mechanisms, with particular emphasis on environmental carcinogens like nitrosamines and aflatoxins. His work increasingly integrates advanced detection technologies, next-generation sequencing, and structural biology approaches to understand mutational signatures and DNA repair pathways. The research shows strong translational potential in cancer prevention, early detection of carcinogens, and development of novel therapeutic strategies. National Cancer Institute Outstanding Investigator Award (1989) Arthur C. Smith Award (1998, 2020) Mutation Research Award for Scientific Excellence (2000) Susan B. Komen Breast Cancer Foundation Award (2000) Thailand's Gold Medal (2004) MERIT Award from the National Cancer Institute (2008) Martin Luther King, Jr., Leadership Award (2009) Founders Award from the Chemical Toxicology Division of the American Chemical Society (2021) Essigmann has mentored numerous graduate students and postdoctoral researchers, with Dr. Bogdan Fedeles representing one prominent example who has published landmark reviews from the Essigmann Lab. His research has been consistently supported by major NIH grants, including a decade-long NCI Outstanding Investigator Award and the current T32 Training Grant in Toxicology. He has served on numerous national review panels, including as past chair of the NIH Chemical Pathology Study Section and service on the Council of the National Institute of Environmental Health Sciences. The Essigmann Lab, housed within MIT's Department of Chemistry, maintains strong collaborative ties with other MIT research groups including the Swager Lab (nanosensors for carcinogen detection). The lab has historically maintained connections with Thailand through research and teaching at the Chulabhorn Research Institute and other Thai institutions, reflecting Essigmann's international recognition for work on problems affecting the developing world.

Paul FeinsteinView profile

Professor

• Molecular Biology
• Neuroscience
• Genetics
• +3 more

Paul Feinstein is a Professor in the Department of Biological Sciences at Hunter College, City University of New York (CUNY) . His research focuses on molecular mechanisms of odorant receptor gene expression, olfactory neuron development, and odor coding. He is affiliated with the Feinstein Lab , which investigates receptor genetics and sensory neuron circuitry. Ph.D., Integrated Program in Cellular, Molecular, and Biophysical Studies, Columbia University College of Physicians and Surgeons B.A. in Biochemistry, University of Pennsylvania Postdoctoral Fellow/Research Associate, The Rockefeller University Feinstein’s research explores how humans perceive odors, with key contributions to understanding odorant receptor gene choice, axon guidance, and glomerular organization in the olfactory system. His work integrates genetic engineering, molecular biology, and neurodevelopmental studies in mouse models. The 15 most recent articles highlight trends in olfactory receptor dynamics , axonal wiring , neurogenetics , and GPCR functionality . These studies span molecular imaging, gene regulation, and sensory neuron mapping, emphasizing receptor-specific mechanisms in neural circuitry. Contact: feinstein@genectr.hunter.cuny.edu | Phone: (212) 650-3169

• Neuroscience
• Sensory Coding
• Neural Circuits
• +4 more

Professor Miguel Maravall is a Professor of Neuroscience at the School of Life Sciences, University of Sussex , where he also serves as Deputy Head of School (Research) . With a background in Physics, his career transitioned to systems neuroscience through postdoctoral work at Cold Spring Harbor Laboratory and SISSA. He led a lab at the Instituto de Neurociencias in Alicante (2004-2015) before joining Sussex. His research focuses on principles of sensory coding in the brain , particularly how neuronal populations encode tactile information via the mouse whisker system . Techniques include two-photon imaging , electrophysiology , and behavioral task design . Funding comes from the MRC , BBSRC , and the Royal Society . His publications highlight trends in sensory adaptation , cortical circuit dynamics , and optical imaging innovations . Awards include the Ramon y Cajal Fellowship , Marie Curie Fellowship , and La Caixa Foundation Studentship . He has held leadership roles in Athena SWAN and Equality, Diversity & Inclusion initiatives at Sussex. Email : M.Maravall@sussex.ac.uk Phone : +44 (0)1273 877263 As co-director of the Sussex Neuroscience Centre (2019-2025), he supports PhD programs and seed funding for researcher innovations. His work bridges experimental and computational neuroscience .

Sundeep KalantryView profile

Associate Professor

• Epigenetic Regulation
• X-Chromosome Inactivation
• Gene Expression
• +3 more

Sundeep Kalantry is an Associate Professor in the Department of Human Genetics at the University of Michigan Medical School. He is also the Associate Chair for Research and an active member of the Cellular and Molecular Biology Program, Cancer Center, and Center for Organogenesis. University of Michigan Medical School Department of Human Genetics His research focuses on epigenetic regulation through X-chromosome inactivation (XCI), using mouse models to study mechanisms like Xist RNA , chromatin modifications , and Polycomb group proteins . The lab investigates how long non-coding RNAs and novel methyltransferases contribute to transcriptional memory and gene silencing. Recent publications highlight work on KDM5C demethylase in XCI, quiescence in embryonic stem cells , and Xist RNA dynamics in early development. Key findings include the role of GSK3 inhibitors in XIST loss and the PRC2-independent function of EZH2 in rRNA methylation. Scientific accolades include the NIH Director's New Innovator Award , Ellison Medical Foundation New Scholar , and multiple University of Michigan collaborative grants. His lab welcomes students and researchers interested in epigenetic mechanisms in development and disease.

• Environmental Epigenetics
• Developmental Origins of Disease
• Nutritional Epigenomics
• +7 more

Dana C. Dolinoy serves as NSF International Chair of Environmental Health Sciences and Professor of Nutritional Sciences and Environmental Health Sciences at the University of Michigan School of Public Health. She is also Faculty Director of the Epigenomics Core at Michigan Medicine and leads the Environmental Epigenetics and Nutrition Laboratory. Dr. Dolinoy holds multiple center memberships including the Rogel Cancer Center, Eisenberg Family Depression Center, and Caswell Diabetes Institute. Dr. Dolinoy earned her PhD in Genetics and Genomics and Integrated Toxicology from Duke University, and MSc in Public Health from Harvard University. She completed postdoctoral training in Radiation Oncology at Duke University Health System. PhD, Duke University, 2007 MSc, Harvard Chan School of Public Health, 2003 BA, Duke University, 1998 Dr. Dolinoy's research focuses on environmental epigenomics and the developmental origins of health and disease. Her work integrates toxicology, epidemiology, and bioinformatics to characterize environmental effects on the epigenome while developing precision environmental epigenomics tools. Her research specifically targets metabolic syndrome, neurodevelopmental disorders, and cancer, with emphasis on vulnerable populations and early environmental exposures that influence adult disease risk. She directs the Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) and is a member of the NIEHS TaRGET II Consortia. Dr. Dolinoy's research program examines the effects of perinatal exposures (metals including lead and endocrine active compounds including phthalates) on the epigenome and longitudinal health risks using human-relevant mouse models and human birth cohort samples. Her work evaluates DNA methylation, non-coding RNA, chromatin structure, and gene expression across multiple tissues with sex-specific analyses. Dr. Dolinoy has received numerous awards including the Norman Kretchmer Memorial Award from the American Society for Nutrition (2011), the Classic Paper of the Year Award from Environmental Health Perspectives (2011), the Association of Schools of Public Health (ASPH)/Pfizer Research Award (2012), and the NIH Director's Transformative Research Award (2015). As an educator, Dr. Dolinoy teaches courses including Environmental Epigenetics and Public Health (EHS660) and Professional Development in Environmental Health Sciences (EHS801). She serves as Associate Editor for Environmental Health Perspectives, Environmental Epigenetics, and Toxicological Sciences, and previously chaired the Gordon Research Conference in Cellular & Molecular Mechanisms of Toxicity. Dr. Dolinoy leads the Environmental Epigenetics and Precision Environmental Health NIEHS R35 RIVER Project and is MPI of the Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes NIDDK R01 study. Her laboratory, the DoGood-Pi Laboratory, investigates how nutritional and environmental factors interact with epigenetic gene regulation to shape health and disease.

Bi-Hung PengView profile

Associate Professor

• Neurobiology
• Virology
• Infectious Diseases
• +10 more

Bi-Hung Peng is an Associate Professor in the Department of Neurobiology at the University of Texas Medical Branch (UTMB). His research focuses on the pathogenesis of intracellular bacterial and viral infections in the central nervous system (CNS), particularly examining CNS entry routes and blood-brain barrier integrity. He utilizes animal models, primary cell cultures (endothelium, neurons, astrocytes), human autopsies, and ECIS technology to study these infections. Additionally, he collaborates on evaluating pathological changes from West Nile virus, SARS, and MERS infections. Education: PhD in Experimental Pathology, UTMB MS in Experimental Pathology, UTMB MS in Agronomy, National Taiwan University BS in Agronomy, National Chung-Hsing University Research Interests include: Neurovirology Viral pathogenesis in the CNS Blood-brain barrier disruption Cytokine signaling in infections Viral disease progression Medical education technology Recent publications highlight research on SARS-CoV-2 sequelae, MERS-CoV modeling, West Nile virus immunology, and novel diagnostic platforms. His work bridges virology, neurobiology, and translational medicine, with a focus on zoonotic pathogens and their CNS effects. Collaborations include work with virologists and immunologists on coronaviruses and alphaviruses. His teaching efforts involve modernizing medical education through virtual microscopy for histology, histopathology, and anatomy courses across multiple UTMB schools.

• Developmental Neuroscience
• Cortical Development
• GABAergic Interneurons
• +4 more

John Rubenstein is a distinguished Professor of Psychiatry at the University of California, San Francisco (UCSF) Weill Institute for Neurosciences within the School of Medicine. His research focuses on the genetic regulation of brain development, particularly cortical development, GABAergic interneuron formation, and neurodevelopmental disorders including autism spectrum disorders and epilepsy. Stanford BS 1977 Chemistry Stanford Biophysics 1982 Membrane Structure and Biogenesis Stanford MD 1986 Pasteur Institute, Paris Postdoc 1986 Mouse Embryology Stanford Residency 1991 Psychiatry Rubenstein's research spans developmental neuroscience, investigating how genetic factors control the formation of neural circuits, particularly focusing on the role of DLX transcription factors in forebrain development. His work bridges molecular genetics with neurophysiology, examining how disruptions in developmental processes lead to neurodevelopmental disorders. He has pioneered research on GABAergic interneuron development and their role in conditions like autism and epilepsy. Analysis of Rubenstein's recent publications reveals a strong focus on transcriptional regulation of cortical development, particularly the role of DLX genes and enhancer elements in controlling neural cell fate. His work increasingly integrates advanced genomic techniques with traditional developmental biology approaches, examining both mouse models and human tissue to understand conserved mechanisms of brain development. Recent work has expanded into translational applications, including cell therapy approaches for epilepsy. W. Maxwell Cowan Award for Developmental Neuroscience (2021) National Academy of Sciences (2020) Ruane Prize for Outstanding Child and Adolescent Psychiatric Research (2016) National Academy of Medicine (2006) Cajal Club Krieg Cortical Discoverer Award (2004) Rubenstein has secured continuous NIH funding since 1992, currently leading multiple R01 grants focused on genetic studies of cortex structure and development, identification of enhancers defining cortical interneuron types, and genetic control of basal telencephalic development. His laboratory has trained numerous scientists who have gone on to establish independent research careers in neuroscience. The lab maintains strong collaborative relationships with other leading neuroscience institutions and has been instrumental in developing resources for the broader neuroscience community. The Rubenstein lab operates within the UCSF Weill Institute for Neurosciences, collaborating closely with other research groups focused on brain development and neurological disorders. The team employs a multidisciplinary approach combining molecular genetics, genomics, electrophysiology, and behavioral analysis to understand the mechanisms underlying proper brain development and how disruptions lead to neurodevelopmental conditions.

• Neurodegenerative Diseases
• Stem Cell Research
• Electrophysiology
• +3 more

Iris-Stefania Pasniceanu is a Postdoctoral Research Associate at the University of Oxford's Nuffield Department of Clinical Neurosciences. She holds a BSc in Biomedical Science and an MSc in Human and Molecular Genetics from the University of Sheffield, followed by a DPhil focused on neurophysiological dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Her research aims to develop novel ALS treatments by repurposing existing drugs, particularly calcium channel blockers, tested in mouse and human stem cell-based models to assess their protective effects on motor neurons. This work is funded by the My Name'5 Doddie Foundation. She is affiliated with the Oxford Motor Neuron Disease Centre and utilizes stem cell technology and electrophysiology in her studies.

Joanna FlorosView profile

Professor

• Surfactant Biology
• Pulmonary Physiology
• Respiratory Genetics
• +3 more

Joanna Floros serves as an Evan Pugh Professor in the Department of Cellular and Molecular Physiology at the Penn State College of Medicine, Hershey Medical Center. Her research program bridges pulmonary physiology, immunology, and genetics with clinical applications in respiratory diseases. Her primary research focuses on surfactant protein biology, particularly SP-A, examining genetic polymorphisms (SNPs), sex-specific differences, and molecular mechanisms in lung immunity. Key areas include respiratory distress syndrome in preterm infants, acute respiratory failure in children, idiopathic pulmonary fibrosis, and responses to pathogens like Klebsiella pneumoniae. Her work integrates molecular biology, proteomics, and transgenic mouse models to investigate how surfactant protein variants regulate alveolar macrophage function, inflammatory responses, and disease susceptibility. Analysis of her 15 most recent publications reveals strong trends in genetic association studies (particularly SNP-SNP interactions), sex-based differences in lung disease outcomes, and translational applications of surfactant protein research across pediatric and adult populations. Her work spans basic science (miRNome analysis, toponome mapping) to clinical correlations (vulvodynia proteomics, respiratory syncytial virus severity). Scientific Awards No specific scientific awards were documented in the provided information. Advising and Grants Dr. Floros maintains an active research program with extensive collaborative networks, as evidenced by her consistent publication record with multidisciplinary teams. While specific grant details aren't provided, her work involves substantial NIH-funded research on surfactant proteins and respiratory diseases. Her advising role is reflected through numerous co-authorships with junior researchers across multiple institutions. Laboratory and Research Teams Her laboratory at Penn State College of Medicine employs integrated approaches combining molecular genetics, proteomics, and animal models to study surfactant protein functions. Key collaborators include David S. Phelps, Vernon M. Chinchilli, and Chintan K. Gandhi, with research spanning pulmonary immunology, genetic epidemiology, and sex-specific disease mechanisms.

Olga LatinovicView profile

Adjunct Assistant Professor

• Virology
• Immunology
• HIV-1 Entry Inhibition
• +4 more

Olga S. Latinovic, PhD, MSc, MBA, MSc is an Adjunct Assistant Professor in the Department of Microbiology and Immunology at the Institute of Human Virology , affiliated with the University of Maryland School of Medicine . Her research focuses on novel antiretroviral therapy strategies targeting HIV-1 entry mechanisms via the CCR5 coreceptor , utilizing humanized mouse models to validate drug combinations for clinical translation. Education: PhD, Lehigh University (2006) Master of Science, Lehigh University (2001) Master of Business Administration, University of Baltimore (2020) Master of Science in Health Care, University of Baltimore (2020) Research Interests: Dr. Latinovic investigates HIV-1 entry inhibition through CCR5-targeting drugs, focusing on minimizing side effects while enhancing therapeutic synergy. Her work spans in vivo model development , drug combination validation , and cross-disciplinary virology (including SARS-CoV-2 receptor analysis). Scientific Contributions: Key studies include CCR5 population dynamics in humanized models (2022), cART intensification with CCR5 inhibitors (2021), and SARS-CoV-2 receptor expression in neuronal cells (2021). Earlier work explored FLSC IgG1 fusion proteins (2016) and Mycoplasma-DnaK oncogenicity (2018).